Background: Each year 604,127 new cases of cervical cancer (CC) are diagnosed, and
341,831 individuals die from the disease. It is the fourth most common cancer among …

Background and Objectives: Cervical cancer (CC) is the fourth most common cause of
cancer-related morbidity and mortality among women worldwide. CC prevention is based on …

In 2020, approximately 604 127 patients were newly diagnosed with cervical cancer and
341 831 died of the disease worldwide. Unfortunately, 85–90% of new cases and deaths …

Cervical cancer screening represents an excellent model system for the development of
personalized cancer-prevention strategies. It has a proven, strong effect on reducing the …

Worldwide, the COVID-19 pandemic disrupted healthcare services, including cervical
cancer management, and an increased burden for this condition is expected. This …

With major advances in understanding the infectious etiology of cervical cancer, preventive
medicine has obtained highly promising new tools. Human papillomavirus (HPV) vaccines …

Objective: A systematic review and meta-analysis were carried out to assess the pooled
proportion of women screened for cervical cancer before and during the COVID-19 …

The age‐standardised incidence of cervical cancer in Europe varies widely by country
(between 3 and 25/100000 women‐years) in 2018. Human papillomavirus (HPV) vaccine …

Cervical cancer is the fourth most common cancer in women, and the seventh overall, with
an estimated 528,000 new cases and 266,000 deaths in 2012 [1]. Almost nine out of ten …

The advent of prophylactic vaccines against human papillomavirus (HPV) infection, the
cause of cervical cancer, and of new molecular methods to screen for this disease have …